About this trial
The goal of this clinical trial is to learn if an individualized lifestyle intervention works to improve weight, diet, physical activity, cardiovascular health, health-related quality of life, and cost-effectiveness in overweight and obese adults aged 45-65 years.
The main questions it aims to answer are:
Does the intervention lead to sustained weight loss after 18 months?
Does the intervention improve cardiovascular risk factors, metabolic markers, and health-related quality of life compared to general written advice?
Is the intervention cost-effective?
Researchers will compare the individualized lifestyle intervention to a control group that receives general written advice on physical activity and diet to see if the intervention provides greater long-term health and economic benefits.
Participants will:
Attend counseling sessions with a health promoter Take part in supervised aerobic and resistance training with a physiotherapist Use swimming facilities and participate in the Lifestyle School Access a digital health coach and the online Lifestyle Tool Complete measurements of body weight, diet, physical activity, and cardiovascular health markers (waist-to-hip ratio, blood pressure, blood lipids, fasting glucose, HbA1c, CRP, and liver enzymes) Complete assessments of resting energy expenditure, aerobic fitness, muscle strength, motivation, and health-related quality of life Provide blood samples at baseline, 6 months, and 18 months for dietary biomarker analysis Contribute data for health economic evaluation to assess cost-effectiveness
Eligibility criteria
Qualifiers
Adults aged 45-65 years at baseline of the original LI-PAD study
Body mass index (BMI) ≥28 and ≤34
Completed the original LI-PAD study
Able and willing to attend follow-up assessments and provide necessary data
Disqualifiers
Known coronary artery disease (clinical symptoms or earlier event)
Inability to understand the language used in the study
Inability to complete follow-up assessments at 18 months
Severe illness or medical condition that, in the investigator's opinion, precludes participation in follow-up assessments
Trial design
Treatments tested in this trial
- Individualized physical activity and diet
Treatment groups
Locations
1Sponsors and collaborators
Vastra Gotaland Region
Lead sponsor
Göteborg University
Collaborator
Chalmers University of Technology
Collaborator